Graypoint LLC’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.27M | Buy |
35,192
+8
| +0% | +$288 | 0.07% | 181 |
|
2025
Q1 | $1.1M | Hold |
35,184
| – | – | 0.07% | 187 |
|
2024
Q4 | $898K | Sell |
35,184
-13
| -0% | -$332 | 0.05% | 209 |
|
2024
Q3 | $996K | Buy |
35,197
+2
| +0% | +$57 | 0.06% | 191 |
|
2024
Q2 | $928K | Sell |
35,195
-8,826
| -20% | -$233K | 0.06% | 188 |
|
2024
Q1 | $1.34M | Sell |
44,021
-6
| -0% | -$182 | 0.1% | 149 |
|
2023
Q4 | $1.24M | Buy |
44,027
+32
| +0.1% | +$899 | 0.1% | 145 |
|
2023
Q3 | $1.19M | Buy |
43,995
+46
| +0.1% | +$1.25K | 0.11% | 134 |
|
2023
Q2 | $1.35M | Hold |
43,949
| – | – | 0.13% | 114 |
|
2023
Q1 | $1.58M | Sell |
43,949
-26
| -0.1% | -$937 | 0.17% | 97 |
|
2022
Q4 | $1.74M | Sell |
43,975
-40,026
| -48% | -$1.58M | 0.21% | 90 |
|
2022
Q3 | $3.38M | Hold |
84,001
| – | – | 0.43% | 57 |
|
2022
Q2 | $3.53M | Sell |
84,001
-481,673
| -85% | -$20.2M | 0.45% | 56 |
|
2022
Q1 | $22M | Buy |
565,674
+90
| +0% | +$3.51K | 2.18% | 10 |
|
2021
Q4 | $22.5M | Sell |
565,584
-45,000
| -7% | -$1.79M | 2.36% | 9 |
|
2021
Q3 | $22.1M | Buy |
610,584
+430,668
| +239% | +$15.6M | 2.71% | 7 |
|
2021
Q2 | $7.38M | Buy |
+179,916
| New | +$7.38M | 0.98% | 30 |
|